HC Wainwright reissued their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) in a research report report published on Friday morning, Benzinga reports. They currently have a $12.00 price target on the stock. Separately, TheStreet cut shares of Anixa Biosciences from a c- rating to a d rating in a research note […]